UBS Group’s Sunshine Biopharma Inc. warrant SBFMW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.65K | Sell |
24,569
-5,162
| -17% | -$1.19K | ﹤0.01% | 7830 |
|
|
2025
Q1 | $6.01K | Buy |
29,731
+28,442
| +2,207% | +$5.75K | ﹤0.01% | 7624 |
|
|
2024
Q4 | $208 | Sell |
1,289
-600
| -32% | -$97 | ﹤0.01% | 8320 |
|
|
2024
Q3 | $198 | Sell |
1,889
-834
| -31% | -$87 | ﹤0.01% | 7861 |
|
|
2024
Q2 | $221 | Buy |
2,723
+2,684
| +6,882% | +$218 | ﹤0.01% | 7900 |
|
|
2024
Q1 | $2 | Sell |
39
-60
| -61% | -$3 | ﹤0.01% | 8015 |
|
|
2023
Q4 | $15 | Sell |
99
-562
| -85% | -$85 | ﹤0.01% | 7878 |
|
|
2023
Q3 | $149 | Sell |
661
-82,471
| -99% | -$18.6K | ﹤0.01% | 7637 |
|
|
2023
Q2 | $31.4K | Buy |
+83,132
| New | +$31.4K | ﹤0.01% | 5625 |
|
|
2023
Q1 | – | Sell |
-400
| Closed | -$132 | – | 8950 |
|
|
2022
Q4 | $132 | Sell |
400
-9,873
| -96% | -$3.26K | ﹤0.01% | 9162 |
|
|
2022
Q3 | $4K | Sell |
10,273
-287
| -3% | -$112 | ﹤0.01% | 8282 |
|
|
2022
Q2 | $8K | Buy |
10,560
+9,948
| +1,625% | +$7.54K | ﹤0.01% | 7301 |
|
|
2022
Q1 | $1K | Buy |
+612
| New | +$1K | ﹤0.01% | 8854 |
|